HALO logo
ADXN
Addex Therapeutics Ltd

ADXN · Addex Therapeutics Ltd

0.021

CHF
-0.0022 (-9.402%)
14/10/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

Fr5.07M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 14/10/2026 12:00:00 AM

Price Chart

Description

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

  • All-Companies
  • Big Candle
  • HALO All
  • HALO Small

Key Fundamentals

EPS 3 yr Growth

-86.40%

EBITDA Margin

NaN%

Operating Cashflow

-SFr2m

Free Cash Flow Return

-30.00%

ROIC

-94.40%

Interest Coverage

NaN

Quick Ratio

1.40

Performance

52 weeks range

Low 0.02 - 0.07

Trade Value (12mth)

US$4,194.00

1 week

4.5%

1 month

-1.69%

YTD

-56.23%

1 year

-64.31%

All time high

75.00

Additional Data

Shares Outstanding (Fully Diluted)

123m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CHF

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Addex Therapeutics Ltd.Public Company
Timothy DyerIndividual
Vincent M. LawtonIndividual
Raymond George HillIndividual
Roger G. MillsIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Addex Therapeutics Ltd (ADXN:SWX)?
Halo FAQ
The current share price of Addex Therapeutics Ltd (ADXN:SWX) is CHFCHF0.02.
2
What is the 52-week high share price for Addex Therapeutics Ltd (ADXN:SWX)?
Halo FAQ
The 52-week high share price for Addex Therapeutics Ltd (ADXN:SWX) is CHFCHF0.07.
3
What is the 52-week low share price for Addex Therapeutics Ltd (ADXN:SWX)?
Halo FAQ
The 52-week low share price for Addex Therapeutics Ltd (ADXN:SWX) is CHFCHF0.02.
4
What is the dividend yield for Addex Therapeutics Ltd (ADXN:SWX)?
Halo FAQ
Addex Therapeutics Ltd (ADXN:SWX) does not pay a dividend.
5
What was Addex Therapeutics Ltd (ADXN:SWX) last dividend payment?
Halo FAQ
Addex Therapeutics Ltd (ADXN:SWX) does not pay a dividend.
6
What is the franking level for Addex Therapeutics Ltd (ADXN:SWX)?
Halo FAQ
Addex Therapeutics Ltd (ADXN:SWX) has a franking level of 0.00%.
7
In which sector is Addex Therapeutics Ltd (ADXN:SWX) classified?
Halo FAQ
Addex Therapeutics Ltd (ADXN:SWX) is classified in the Healthcare.